Litmaps vs Rayyan (2026)

Litmaps

by Litmaps

Rayyan

by Rayyan

Pros

• ✓Literature alerts with automatic Litmap updates set the platform apart from snapshot-only visualization tools. Weekly configurable alerts (a Pro feature at $10/month) surface new papers matching your research area and update existing Litmaps, an ongoing-monitoring capability that Connected Papers and Inciteful do not offer natively.
• ✓Accessible $10/month Pro pricing with country-specific discounts widens global access. The discount program makes Pro affordable for researchers in lower-income regions where tool budgets are constrained, going further than tools with flat global pricing.
• ✓The free tier allows genuine evaluation of the core visualization workflow: 2 Litmaps and 100 articles per Map are enough to test citation-network navigation before upgrading, though literature alerts (the primary differentiator) require Pro to evaluate.

Limitations

• ⚠Citation visualization is one workflow among many. Litmaps maps citation networks and sends alerts but does not generate narrative summaries, extract structured data, or conduct autonomous multi-step research, so synthesis work needs a companion tool such as Elicit ($49/mo billed annually) or Undermind ($16/mo billed annually).
• ⚠Literature alerts are Pro-only with no free evaluation: the primary differentiating feature (weekly configurable alerts that update Litmaps with new papers) sits behind the $10/month Pro subscription, so free-tier users cannot assess the most distinctive capability before committing.
• ⚠Discovery relies on citation-graph and metadata coverage rather than full text or citation context: Litmaps shows how papers connect but not whether later work supports or contradicts them, so credibility assessment still needs a tool like Scite.ai ($12/mo billed annually).

Pros

• ✓Academic-friendly pricing makes systematic review tools accessible where enterprise alternatives cannot. The permanent Free tier (3 reviews, 2 reviewers), Essential at $4.99/seat/month annual, and Advanced at $8.33/seat/month annual sit far below Covidence ($149+/month) and DistillerSR (custom pricing), removing cost as a barrier for graduate students and early-career researchers.
• ✓AI duplicate detection is widely regarded as best-in-category for systematic reviews. It is consistently cited as a primary reason researchers choose Rayyan, cutting time spent on manual deduplication across large citation sets exported from PubMed, Scopus, and Web of Science.
• ✓A 1M+ researcher global base across 20,000+ institutions, plus university library endorsements, provides strong community validation. Research guides at the University of Hawaii, University of Mississippi, and other major institutions recommend Rayyan, and a PMC/NIH peer-reviewed study confirms 97-99% AI screening sensitivity for the Predictor engine.

Limitations

• ⚠Less depth than enterprise systematic review platforms. Rayyan suits academic and individual systematic review but lacks the workflow customization, advanced audit trails, and enterprise-grade reporting that Covidence or DistillerSR provide for high-stakes regulatory and clinical evidence synthesis.
• ⚠Mobile free-tier friction and unexpected collaborator costs: Google Play reviewers report the 100-decision mobile screening limit on the free tier as a meaningful constraint, and invited collaborators on reviews where only the owner holds a paid subscription can face unexpected payment requirements to complete their screening tasks.
• ⚠Specialized for systematic reviews, with no literature discovery or citation analysis. Rayyan covers the evidence synthesis workflow (screening, deduplication, PRISMA) but lacks the deeper literature search of Undermind ($16/mo billed annually), the citation context analysis of Scite.ai ($12/mo billed annually), or the open-web synthesis of Gemini Deep Research.